Artigo Original
Chen et al
Efeitos e mecanismos da DSR na anti-hipertensão
Arq Bras Cardiol. 2017; 108(3):237-245
1. Chowdhury EK, Owen A, KrumH, Wing LM, NelsonMR, Reid CM; Second
AustralianNational Blood Pressure StudyManagement Committee. Systolic
blood pressure variability is an important predictor of cardiovascular
outcomes in elderly hypertensive patients. J Hypertens. 2014;32(3):525-33.
2. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-
related disease, 2001. Lancet. 2008;371(9623):1513-8.
3. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al; PURE
(Prospective Urban Rural Epidemiology) Study investigators. Prevalence,
awareness, treatment, and control of hypertension in rural and urban
communities in high-, middle-, and low-income countries. JAMA.
2013;310(9):959-68.
4. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus
K, et al. Catheter-based renal sympathetic denervation for resistant
hypertension: a multicentre safety and proof-of-principle cohort study.
Lancet. 2009;373(9671):1275-81.
5. Krum H, Schlaich MP, Sobotka PA, Bohm M, Mahfoud F, Rocha-Singh K,
et al. Percutaneous renal denervation in patients with treatment-resistant
hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet.
2014;383(9917):622-9. Erratum in: Lancet. 2014;383(9917):602.
6. Esler MD, Bohm M, Sievert H, Rump CL, Schmieder RE, Krum H, et al.
Catheter-based renal denervation for treatment of patients with treatment-
resistant hypertension: 36 month results from the SYMPLICITY HTN-2
randomized clinical trial. Eur Heart J. 2014;35(26):1752-9.
7. Davis MI, Filion KB, Zhang D, Eisenberg MJ, Afilalo J, Schiffrin EL, et al.
Effectiveness of renal denervation therapy for resistant hypertension: a
systematic reviewandmeta-analysis. J AmColl Cardiol. 2013;62(3):231-41.
8. Pancholy SB, Shantha GP, Patel TM, Sobotka PA, Kandzari DE. Meta-
analysis of the effect of renal denervation on blood pressure and pulse
pressure in patients with resistant systemic hypertension. J AmColl Cardiol.
2014;114(6):856-61.
9. Bakris GL, Townsend RR, Liu M, Cohen SA, D’Agostino R, Flack JM, et al;
SYMPLICITY HTN-3 Investigators. Impact of renal denervation on 24-hour
ambulatory blood pressure: results from SYMPLICITY HTN-3. J Am Coll
Cardiol. 2014;64(11):1071-8.
10. Tiroch K, Schmitz I, Seyfarth M, Szymanski J. TCT-210 Decrease of the
norepinephrine release from sympathetic nerves during renal denervation.
J Am Coll Cardiol. 2012;60(Suppl):B61-2.
11. Machino T, Murakoshi N, Sato A, Xu D, Hoshi T, Kimura T, et al. Anti-
hypertensive effect of radiofrequency renal denervation in spontaneously
hypertensive rats. Life Sci. 2014;110(2):86-92.
12. Uri K, Fagyas M, Manyine Siket I, Kertesz A, Csanadi Z, Sandorfi G, et al.
New perspectives in the renin-angiotensin-aldosterone system (RAAS)
IV: circulating ACE2 as a biomarker of systolic dysfunction in human
hypertension and heart failure. PLoS One. 2014;9(4):e87845.
13. Polonia JJ, Martins L, Pinto F, Nazare J. Estimation of the predictive value
for hypertension of different indices of obesity in the scope of a national
representative survey of hypertension (PHYSA). J Am Soc Hypertens.
2014;8(4 Suppl):e83.
14. Henegar JR, Zhang Y, De Rama R, Hata C, Hall ME, Hall JE. Catheter-
based radiorefrequency renal denervation lowers blood pressure in obese
hypertensive dogs. Am J Hypertens. 2014;27(10):1285-92.
15. Rimoldi SF, Scheidegger N, Scherrer U, Farese S, Rexhaj E, Moschovitis A, et al.
Anatomicaleligibilityoftherenalvasculatureforcatheter-basedrenaldenervation
inhypertensivepatients.JACCCardiovascInterv.2014;7(2):187-92.
16. Brandt MC, Reda S, Mahfoud F, Lenski M, BohmM, HoppeUC. Effects of renal
sympatheticdenervationonarterialstiffnessandcentralhemodynamicsinpatients
withresistanthypertension.JAmCollCardiol.2012;60(19):1956-65.
17. Schirmer SH, Sayed MM, Reil JC, Ukena C, Linz D, Kindermann M, et al.
Improvements in left ventricular hypertrophy and diastolic function following
renaldenervation:effectsbeyondbloodpressureandheartratereduction.JAm
CollCardiol.2014;63(18):1916-23.
18. OttC,MahfoudF,SchmidA,DittingT,VeelkenR,EwenS,etal.Improvementof
albuminuriaafterrenaldenervation.IntJCardiol.2014;173(2):311-5.
19. ScherlagMA,ScherlagBJ.Arandomizedcomparisonofpulmonaryveinisolation
with versus without concomitant renal artery denervation in patients with
refractory symptomatic atrial fibrillation and resistant hypertension. J AmColl
Cardiol.2013;62(12):1129-30.
20. Davies JE, Manisty CH, Petraco R, Barron AJ, Unsworth B, Mayet J, et al. First-
in-man safety evaluation of renal denervation for chronic systolic heart failure:
primaryoutcomefromREACH-Pilotstudy.IntJCardiol.2013;162(3):189-92.
21. Kumai T, Tateishi T, Tanaka M, Watanabe M, Shimizu H, Kobayashi S.
Tyrosine hydroxylase antisense gene therapy causes hypotensive effects in the
spontaneouslyhypertensiverats.JHypertens.2001;19(10):1769-73.
22. WybraniecMT, Mizia-Stec K, Trojnarska O, Chudek J, Czerwienska B, Wikarek
M,etal.Lowplasmarenalaseconcentrationinhypertensivepatientsaftersurgical
repairofcoarctationofaorta.JAmSocHypertens.2014;8(7):464-74.
23. DesirGV,TangL,WangP,LiG,Sampaio-MaiaB,Quelhas-SantosJ,etal.Renalase
lowers ambulatory blood pressure by metabolizing circulating adrenaline. J Am
HeartAssoc.2012;1(4):e002634.
24. Jiang W, Guo Y, Tan L, Tang X, Yang Q, Yang K. Impact of renal denervation on
renalaseexpression inadultratswithspontaneoushypertension.ExpTherMed.
2012;4(3):493-6.
25. Munoz MC, Burghi V, Miquet JG, Giani JF, Banegas RD, Toblli JE, et al.
DownregulationoftheACE2/Ang-(1-7)/Masaxisintransgenicmiceoverexpressing
GH.JEndocrinol.2014;221(2):215-27.
26. ZhengJ,LiG,ChenS,BihlJ,BuckJ,ZhuY,etal.ActivationoftheACE2/Ang-(1-7)/
Maspathwayreducesoxygen-glucosedeprivation-inducedtissueswelling,ROS
production, and cell death in mouse brain with angiotensin II overproduction.
Neuroscience.2014;273:39-51.
27. Stegbauer J, Oberhauser V, VonendO, Rump LC. Angiotensin-(1-7) modulates
vascularresistanceandsympatheticneurotransmissioninkidneysofspontaneously
hypertensiverats.CardiovascRes.2004;61(2):352-9.
28. BykuM, Macarthur H,Westfall TC. Inhibitory effects of angiotensin-(1-7) on the
nervestimulation-inducedreleaseofnorepinephrineandneuropeptideYfromthe
mesentericarterialbed.AmJPhysiolHeartCircPhysiol.2010;298(2):H457-65.
29. Gironacci MM, Valera MS, Yujnovsky I, Peña C. Angiotensin-(1-7) inhibitory
mechanism of norepinephrine release in hypertensive rats. Hypertension.
2004;44(5):783-7.
30. LopezVerrilliMA,RodriguezFermepínM,LongoCarbajosaN,LandaS,Cerrato
BD, García S, et al. Angiotensin-(1-7) through Mas receptor up-regulates
neuronalnorepinephrinetransporterviaAktandErk1/2-dependentpathways.J
Neurochem.2012;120(1):46-55.
Referências
Fontes de Financiamento
O presente estudo foi patrocinado pela Fundação da
Ci ncia Natural da Província de Hunan, China (10JJ3048), e
por Fundos De Pesquisas Fundamentais para as Universidades
Centrais da Universidade Centro-Sul (2015zzts123).
Vinculação Acadêmica
Este artigo é parte de dissertação de Mestrado de Wei Chen
pela Central South University, Changsha - Hunan.
245
